Performance of MRVI Maravai Lifesciences | -13.2% in 12m
Compare MRVI with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Maravai Lifesciences with its related Sector/Index XLV
![Compare Maravai Lifesciences with its related Sector/Index XLV](https://www.valueray.com/images/chart/MRVI.NASDAQ_perf.png)
Performance Duell MRVI vs XLV
TimeFrame | MRVI | XLV |
---|---|---|
1 Week | 0.00% | -2.07% |
1 Month | -0.44% | 4.37% |
3 Months | 6.97% | 5.66% |
6 Months | 24.3% | 6.23% |
12 Months | -13.2% | 17.65% |
YTD | 34.3% | 11.77% |
Rel. Perf. 1m | -0.88 | |
Rel. Perf. 3m | 0.45 | |
Rel. Perf. 6m | 0.60 | |
Rel. Perf. 12m | 0.60 | |
Spearman 1m | 0.33 | 0.82 |
Spearman 3m | 0.62 | 0.89 |
Is Maravai Lifesciences a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Maravai Lifesciences (NASDAQ:MRVI) is currently (September 2024)
not a good stock to buy. It has a ValueRay Fundamental Rating of -32.96 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MRVI as of September 2024 is 8.49. This means that MRVI is currently overvalued and has a potential downside of -6.19% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MRVI as of September 2024 is 8.49. This means that MRVI is currently overvalued and has a potential downside of -6.19% (Sold with Premium).
Is MRVI a buy, sell or hold?
- Strong Buy: 7
- Buy: 1
- Hold: 4
- Sell: 0
- Strong Sell: 0
Values above 0%: MRVI is performing better - Values below 0%: MRVI is underperforming
Compare MRVI with Broad Market Indices
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 4.14% | -3.93% | 17.63% | -35.33% |
US NASDAQ 100 | QQQ | 5.79% | -2.52% | 21.76% | -33.00% |
US Dow Jones Industrial 30 | DIA | 2.82% | -4.24% | 19.01% | -31.65% |
German DAX 40 | DBXD | 3.24% | -5.84% | 21.48% | -27.75% |
UK FTSE 100 | ISFU | 2.25% | -6.71% | 11.99% | -31.31% |
Shanghai Shenzhen CSI 300 | CSI 300 | 2.68% | 1.87% | 30.58% | -2.24% |
Hongkong Hang Seng | HSI | 2.22% | -5.21% | 23.80% | -7.31% |
Japan Nikkei 225 | EXX7 | 7.12% | -6.12% | 34.44% | -19.01% |
India NIFTY 50 | INDA | 2.10% | -3.05% | 15.87% | -37.46% |
Brasil Bovespa | EWZ | 1.71% | -7.32% | 32.82% | -13.39% |
MRVI Maravai Lifesciences vs. Sectors
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 4.07% | -1.03% | 16.94% | -37.67% |
Consumer Discretionary | XLY | 2.52% | -5.83% | 22.32% | -19.24% |
Consumer Staples | XLP | -0.58% | -6.51% | 12.49% | -31.30% |
Energy | XLE | 5.77% | 0.68% | 23.99% | -11.01% |
Financial | XLF | 3.17% | -7.16% | 14.41% | -43.89% |
Health Care | XLV | 2.07% | -4.81% | 18.08% | -30.80% |
Industrial | XLI | 4.24% | -3.59% | 20.10% | -34.22% |
Materials | XLB | 4.66% | -2.03% | 22.21% | -24.80% |
Real Estate | XLRE | -0.18% | -5.45% | 12.54% | -36.52% |
Technology | XLK | 7.45% | -2.10% | 25.56% | -31.47% |
Utilities | XLU | 0.50% | -4.61% | 2.19% | -36.91% |
Aerospace & Defense | XAR | 5.21% | -4.44% | 19.84% | -39.49% |
Biotech | XBI | 4.68% | -2.64% | 27.79% | -35.76% |
Homebuilder | XHB | 4.40% | -3.86% | 16.47% | -50.75% |
Retail | XRT | 4.98% | 0.07% | 27.56% | -31.80% |
Does Maravai Lifesciences outperform its market, is MRVI a Sector Leader?
No, over the last 12 months Maravai Lifesciences (MRVI) made -13.15%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 17.65%.
Over the last 3 months MRVI made 6.97%, while XLV made 5.66%.
No, over the last 12 months Maravai Lifesciences (MRVI) made -13.15%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 17.65%.
Over the last 3 months MRVI made 6.97%, while XLV made 5.66%.
Period | MRVI | XLV | S&P 500 |
---|---|---|---|
1 Month | -0.44% | 4.37% | 3.49% |
3 Months | 6.97% | 5.66% | 1.39% |
12 Months | -13.15% | 17.65% | 22.18% |